US 2026/0061079 A1Published application

BBB interacting capsids

AssigneeuniQure biopharma B.V.

Inventors- Anggakusuma, Elena Maria Santidrian Yebra-Pimentel

Life of this patent

Estimating the term…

Abstract

The present invention relates to the fields of medicine, molecular biology, and gene therapy. In particular, the invention relates to novel recombinant adeno-associated virus capsids, uses thereof and methods of manufacturing the novel recombinant adeno-associated virus capsids.

Claims17

Dependent claims

A recombinant adeno-associated virus (rAAV) capsid comprising a binding moiety, wherein the binding moiety confers to the rAAV capsid a phenotype of increased interaction with Transferrin receptor protein 1 (TfR1) as compared to a control rAAV capsid not comprising the binding moiety.

Dependencies are inferred from the claim text.

Facts

Application: 19/307,083Filed 22 Aug 2025
Priority: EP 24195864.422 Aug 2024
Published: 5 Mar 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 48/0058
Characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered: nucleic acids adapted for tissue…
C07K 14/705
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants
A61K 38/177
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants
A61K 48/005
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy:…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results